A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Ban-Xia-Xie-Xin-Tang

Ban-Xia-Xie-Xin-Tang (BXXXT) is a classical formula from Shang-Han-Lun which is one of the earliest books of TCM clinical practice. In this work, we investigated the therapeutic mechanisms of BXXXT for the treatment of multiple diseases using a network pharmacology approach. Here three BXXXT representative diseases (colitis, diabetes mellitus, and gastric cancer) were discussed, and we focus on in silico methods that integrate drug-likeness screening, target prioritizing, and multilayer network extending. A total of 140 core targets and 72 representative compounds were finally identified to elucidate the pharmacology of BXXXT formula. After constructing multilayer networks, a good overlap between BXXXT nodes and disease nodes was observed at each level, and the network-based proximity analysis shows that the relevance between the formula targets and disease genes was significant according to the shortest path distance (SPD) and a random walk with restart (RWR) based scores for each disease. We found that there were 22 key pathways significantly associated with BXXXT, and the therapeutic effects of BXXXT were likely addressed by regulating a combination of targets in a modular pattern. Furthermore, the synergistic effects among BXXXT herbs were highlighted by elucidating the molecular mechanisms of individual herbs, and the traditional theory of “Jun-Chen-Zuo-Shi” of TCM formula was effectively interpreted from a network perspective. The proposed approach provides an effective strategy to uncover the mechanisms of action and combinatorial rules of BXXXT formula in a holistic manner.

[1]  Ming Yang,et al.  A novel adaptive ensemble classification framework for ADME prediction , 2018, RSC advances.

[2]  A. Khosrowbeygi,et al.  Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus , 2016, Endocrine.

[3]  Chengfang Yao,et al.  Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10- and IL-6-dependent manners. , 2007, International immunopharmacology.

[4]  W. Xie,et al.  Diabetes is an inflammatory disease: evidence from traditional Chinese medicines , 2011, Diabetes, obesity & metabolism.

[5]  P. Aloy,et al.  Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.

[6]  Ming Yang,et al.  Development of in Silico Models for Predicting P-Glycoprotein Inhibitors Based on a Two-Step Approach for Feature Selection and Its Application to Chinese Herbal Medicine Screening. , 2015, Molecular pharmaceutics.

[7]  K. Fung,et al.  Screening for Anti‐inflammatory and Bronchorelaxant Activities of 12 Commonly Used Chinese Herbal Medicines , 2012, Phytotherapy research : PTR.

[8]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[9]  Yibin Feng,et al.  A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae , 2017, Molecules.

[10]  L. Ge,et al.  DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews , 2018, Acta Diabetologica.

[11]  R. Wilson,et al.  Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation , 2016, Oncotarget.

[12]  Yonghua Wang,et al.  A Systems Biology Approach to Understanding the Mechanisms of Action of Chinese Herbs for Treatment of Cardiovascular Disease , 2012, International journal of molecular sciences.

[13]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[14]  R. Saghiri,et al.  Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus , 2016, Enzyme research.

[15]  C. Ortutay,et al.  Molecular Data Analysis Using R , 2016 .

[16]  Jing Zhao,et al.  Bioinformatics Analysis for the Antirheumatic Effects of Huang-Lian-Jie-Du-Tang from a Network Perspective , 2013, Evidence-based complementary and alternative medicine : eCAM.

[17]  Yanxiang Zhang,et al.  Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer , 2017, Oncology letters.

[18]  Shun Xu,et al.  Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus , 2011, Comput. Biol. Chem..

[19]  M. Newman,et al.  Finding community structure in networks using the eigenvectors of matrices. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.

[20]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[21]  Gong-Hua Li,et al.  MOfinder: A Novel Algorithm for Detecting Overlapping Modules from Protein-Protein Interaction Network , 2012, Journal of biomedicine & biotechnology.

[22]  Gary D Bader,et al.  BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.

[23]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[24]  V. Morsch,et al.  Platelet aggregation and serum adenosine deaminase (ADA) activity in pregnancy associated with diabetes, hypertension and HIV , 2016, Cell biochemistry and function.

[25]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[26]  N. Subedi,et al.  Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus , 2017, BMJ Open Diabetes Research and Care.

[27]  Ian M. Donaldson,et al.  BIND: the Biomolecular Interaction Network Database , 2001, Nucleic Acids Res..

[28]  Shinn-Jang Hwang,et al.  Modern use of Chinese herbal formulae from Shang-Han Lun. , 2009, Chinese medical journal.

[29]  T. Pabst,et al.  The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia , 2018, Cancers.

[30]  P. Wei,et al.  Banxia Xiexin decoction ameliorated cognition via the regulation of insulin pathways and glucose transporters in the hippocampus of APPswe/PS1dE9 mice , 2018, International journal of immunopathology and pharmacology.

[31]  Shao Li,et al.  [Framework and practice of network-based studies for Chinese herbal formula]. , 2007, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[32]  Hongjun Yang,et al.  Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula. , 2013, Molecular bioSystems.

[33]  Yibin Feng,et al.  A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines , 2017, Molecules.

[34]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[35]  A. Mammoto,et al.  RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity. , 2014, The Journal of clinical investigation.

[36]  Xue Xu,et al.  A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.

[37]  A. Fusco,et al.  The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells , 2018, Oncotarget.

[38]  M. Newman,et al.  Finding community structure in very large networks. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[39]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[40]  CHUN WEI YAP,et al.  PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..

[41]  Joel S. Bader,et al.  NeMo: Network Module identification in Cytoscape , 2010, BMC Bioinformatics.

[42]  Réka Albert,et al.  Near linear time algorithm to detect community structures in large-scale networks. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[43]  Martin H. Schaefer,et al.  HIPPIE v2.0: enhancing meaningfulness and reliability of protein–protein interaction networks , 2016, Nucleic Acids Res..

[44]  W. Liu,et al.  Rapid, reliable, and sensitive detection of adenosine deaminase activity by UHPLC‐Q‐Orbitrap HRMS and its application to inhibitory activity evaluation of traditional Chinese medicines , 2018, Journal of pharmaceutical and biomedical analysis.

[45]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[46]  A. Fusco,et al.  A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis , 2016, Oncotarget.

[47]  A. Boligon,et al.  Syzygium cumini seed extract ameliorates adenosine deaminase activity and biochemical parameters but does not alter insulin sensitivity and pancreas architecture in a short-term model of diabetes , 2015, Journal of complementary & integrative medicine.

[48]  C. Quezada,et al.  Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy , 2017, Scientific Reports.

[49]  Minoru Kanehisa,et al.  The KEGG database. , 2002, Novartis Foundation symposium.

[50]  Chen Fang-Pey,et al.  Modern use of Chinese herbal formulae from Shang-Han Lun. , 2009 .

[51]  Xiaohui Chen,et al.  Integrative investigation of Semen Strychni nephrotoxicity and the protective effect of Radix Glycyrrhizae by a UPLC-MS/MS method based cell metabolomics strategy in HEK 293t cell lysates , 2015 .

[52]  A. Ullrich,et al.  SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. , 1999, Cancer research.

[53]  G. Liou,et al.  Adenosine Deaminase-2–Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p , 2017, Investigative ophthalmology & visual science.

[54]  T. Efferth,et al.  Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid. , 2013, International journal of nanomedicine.

[55]  A. Geater,et al.  Diagnostic scoring system for tuberculous meningitis among adult patients with non-suppurative and non-bacterial meningitis. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[56]  M E J Newman,et al.  Finding and evaluating community structure in networks. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[57]  S. Yamagishi,et al.  Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes , 2015, Molecular medicine.

[58]  Baocun Sun,et al.  VEGFR2 regulates endothelial differentiation of colon cancer cells , 2017, BMC Cancer.

[59]  J. Baldissarelli,et al.  Effect of gallic acid on purinergic signaling in lymphocytes, platelets, and serum of diabetic rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[60]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[61]  Lu Huang,et al.  Update of TTD: Therapeutic Target Database , 2009, Nucleic Acids Res..

[62]  Susmita Datta,et al.  Methods for evaluating clustering algorithms for gene expression data using a reference set of functional classes , 2006, BMC Bioinformatics.

[63]  J. Mansfield,et al.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.

[64]  Xiaoling Zhang,et al.  The multi-target capabilities of the compounds in a TCM used to treat sepsis and their in silico pharmacology. , 2013, Complementary therapies in medicine.

[65]  Natalie Wilson Human Protein Reference Database , 2004, Nature Reviews Genetics.

[66]  Gary D Bader,et al.  Biological Network Exploration with Cytoscape 3 , 2014, Current protocols in bioinformatics.

[67]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[68]  Bo Zhang,et al.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..

[69]  Yang Chen,et al.  Open Access Research Article Identification of Responsive Gene Modules by Network-based Gene Clustering and Extending: Application to Inflammation and Angiogenesis , 2022 .

[70]  J. Mestres,et al.  A ligand-based approach to mining the chemogenomic space of drugs. , 2008, Combinatorial chemistry & high throughput screening.

[71]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[72]  Bo Zhang,et al.  An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.

[73]  John O. Woods,et al.  Prediction and Validation of Gene-Disease Associations Using Methods Inspired by Social Network Analyses , 2013, PloS one.

[74]  Xue Xu,et al.  A Systems Biology Approach to Uncovering Pharmacological Synergy in Herbal Medicines with Applications to Cardiovascular Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.

[75]  X. Yin,et al.  Determination of glycyrrhizin in radix glycyrrhizae and its preparations by capillary zone electrophoresis. , 1999, Biomedical chromatography : BMC.

[76]  Xiaofeng Cui,et al.  Tumor Suppressor PTPRJ Is a Target of miR‐155 in Colorectal Cancer , 2017, Journal of cellular biochemistry.

[77]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[78]  S. Koçbiyik,et al.  The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia , 2016, Nordic journal of psychiatry.

[79]  Gang Chen,et al.  Modifying the DPClus algorithm for identifying protein complexes based on new topological structures , 2008, BMC Bioinformatics.

[80]  H. He,et al.  Effects of TNF-α on Cementoblast Differentiation, Mineralization, and Apoptosis , 2015, Journal of dental research.

[81]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[82]  Xin Yao,et al.  Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network , 2011, BMC Systems Biology.

[83]  Bing Wu,et al.  Efficacy of Modified Ban Xia Xie Xin Decoction on Functional Dyspepsia of Cold and Heat in Complexity Syndrome: A Randomized Controlled Trial , 2013, Evidence-based complementary and alternative medicine : eCAM.

[84]  Ioannis Xenarios,et al.  DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..

[85]  Alan F. Scott,et al.  McKusick's Online Mendelian Inheritance in Man (OMIM®) , 2008, Nucleic Acids Res..

[86]  Juan Ye,et al.  Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice. , 2015, Journal of ethnopharmacology.

[87]  Martin Rosvall,et al.  Maps of random walks on complex networks reveal community structure , 2007, Proceedings of the National Academy of Sciences.

[88]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[89]  Jean-Marc Schwartz,et al.  A global view of drug-therapy interactions , 2007, BMC pharmacology.

[90]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[91]  Damian Szklarczyk,et al.  STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data , 2015, Nucleic Acids Res..

[92]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[93]  Shao Li,et al.  [Network target: a starting point for traditional Chinese medicine network pharmacology]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[94]  Yanqiong Zhang,et al.  A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Wu Tou Tang Acting on Rheumatoid Arthritis by Integrating Network Analysis , 2013, Evidence-based complementary and alternative medicine : eCAM.

[95]  A. Jimeno,et al.  Apatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumors. , 2015, Drugs of today.

[96]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[97]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[98]  Martin H. Schaefer,et al.  HIPPIE: Integrating Protein Interaction Networks with Experiment Based Quality Scores , 2012, PloS one.

[99]  G. Ji,et al.  Navigating Traditional Chinese Medicine Network Pharmacology and Computational Tools , 2013, Evidence-based complementary and alternative medicine : eCAM.

[100]  A. Barclay,et al.  Essential Roles for Dok2 and RasGAP in CD200 Receptor-Mediated Regulation of Human Myeloid Cells1 , 2009, The Journal of Immunology.

[101]  Mao-Feng Sun,et al.  Prescription patterns of traditional Chinese medicine for peptic ulcer disease in Taiwan: A nationwide population-based study. , 2015, Journal of ethnopharmacology.